Immunome Correlations
| IMNM Stock | USD 22.16 0.28 1.25% |
The current 90-days correlation between Immunome and Pharvaris BV is 0.53 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunome moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunome moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Immunome Correlation With Market
Poor diversification
The correlation between Immunome and DJI is 0.74 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Immunome Stock
| 0.69 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.66 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.66 | EQ | Equillium | PairCorr |
| 0.63 | DNLI | Denali Therapeutics | PairCorr |
| 0.8 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.87 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.84 | DRTS | Alpha Tau Medical | PairCorr |
| 0.81 | DSGN | Design Therapeutics | PairCorr |
| 0.64 | SAB | Sonic Healthcare Earnings Call This Week | PairCorr |
| 0.88 | 0P6S | Bayer AG NA | PairCorr |
| 0.69 | DVAX | Dynavax Technologies Earnings Call This Week | PairCorr |
Moving against Immunome Stock
| 0.74 | OSE | OSE Pharma SA | PairCorr |
| 0.74 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.59 | DRMA | Dermata Therapeutics | PairCorr |
| 0.56 | VCEL | Vericel Corp Ord | PairCorr |
| 0.51 | VCYT | Veracyte | PairCorr |
| 0.37 | ABNX | Abionyx Pharma SA | PairCorr |
| 0.34 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.79 | DTIL | Precision BioSciences | PairCorr |
| 0.73 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.72 | VSTM | Verastem | PairCorr |
| 0.71 | IGS1 | India Globalization | PairCorr |
| 0.71 | VRAX | Virax Biolabs Group | PairCorr |
| 0.71 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.69 | VKTX | Viking Therapeutics | PairCorr |
| 0.69 | CDTTW | Conduit Pharmaceuticals | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immunome Stock performing well and Immunome Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunome's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PHVS | 3.32 | 0.23 | 0.07 | 0.21 | 3.45 | 6.58 | 27.81 | |||
| SYRE | 2.72 | 0.75 | 0.26 | 0.67 | 2.45 | 7.15 | 20.03 | |||
| NTLA | 3.71 | 0.25 | 0.08 | 0.15 | 4.21 | 10.12 | 23.60 | |||
| UPB | 4.71 | (1.09) | 0.00 | (1.47) | 0.00 | 7.84 | 57.85 | |||
| BHVN | 4.04 | 0.70 | 0.17 | 60.59 | 3.50 | 10.23 | 29.39 | |||
| MAZE | 2.78 | 0.65 | 0.20 | 1.65 | 2.68 | 6.77 | 20.03 | |||
| VERA | 3.34 | 0.59 | 0.22 | 0.35 | 2.55 | 8.21 | 17.87 | |||
| ABCL | 3.28 | (0.48) | 0.00 | (0.10) | 0.00 | 6.33 | 28.69 | |||
| CLDX | 2.52 | (0.01) | 0.00 | 0.05 | 2.99 | 6.44 | 14.68 | |||
| ZBIO | 5.66 | 0.32 | 0.01 | (0.13) | 11.64 | 12.20 | 68.95 |
Immunome Corporate Management
| Matthew Robinson | Chief Officer | Profile | |
| Michael Morin | Chief Scientist | Profile | |
| Philip Roberts | Chief Officer | Profile | |
| Robert Lapetina | Principal Officer | Profile | |
| JD Esq | General Officer | Profile | |
| Purnanand Sarma | CEO Pres | Profile | |
| Sandra Esq | Gen Officer | Profile |